ABSTRACT
We present a 67-year-old man who had undergone aortobifemoral synthetic graft surgery one year earlier. The patient experienced thrombosis of the graft nine months after the operation, and thrombectomy of the graft was planned. However, the patient refused to undergo repeat surgery for thrombus removal and was referred to our center for possible endovascular treatment. We treated the patient with percutaneous aspiration thrombectomy. The thrombi were chronic in nature but could be removed with minimal residue in any part of the graft by using repeated aspiration thrombectomy with 7 F guiding catheters. Underlying stenosis of both distal graft anastomoses was treated with percutaneous balloon angioplasty, and a self-expanding stent was deployed on the right distal anastomosis. A small fragment of thrombus embolized to the right popliteal artery and was removed with aspiration thrombectomy through a second antegrade puncture on the right side. We believe this is the first report of aspiration thrombectomy for an aortobifemoral graft thrombosis. The method was successful despite the chronic nature of the thrombi. Manual aspiration thrombectomy with largebore guiding catheters can be used as an effective recanalization method for delayed aortobifemoral graft occlusion and could be regarded as a good alternative technique to surgical thrombectomy in selected patients.
1a and 1c). Distally, the deep femoral artery with reconstructed collateral circulation showed occlusion in both the common and superficial arteries on the left and right sides; the reconstructed common femoral artery displayed diminished caliber in both the deep and superficial femoral arteries (Fig. 1b) . Using ultrasonography guidance, 7 F sheaths were inserted in both limbs of the graft. A 7 F straight-tip guiding catheter (Cordis Corporation, Miami, Florida, USA) was inserted through the vascular sheath to the most distal part of the thrombus, and suction was performed manually with a 20-mL syringe. A guide wire was not used to advance the guiding catheter in the thrombosed graft. Once the thrombus was engaged, the catheter was withdrawn while maintaining suction to hold the thrombus. The thrombi were removed with minimal residue, and recanalization was achieved in both limbs of the graft, the main body of the graft, and the infrarenal abdominal aorta using repeated aspiration thrombectomy, as described ( Fig. 2a and 2b ). Most thrombi aspirated were organized and in a chronic stage, as expected. Approximately 20 passes of the guiding catheter were made on each side to remove the entire thrombus. We used a 7 F multipurpose-type, angled, guiding catheter (Cordis Corporation) to clean the thrombus adherent to the wall of the graft. Initially, we did not remove any of the thrombus at the most proximal and most distal parts of the thrombus. This was left to the end of the procedure to prevent embolization of the thrombus proximally to the renal arteries and distally to the limb arteries. A confirmation angiogram showed that the underlying cause of the thrombosis was bilateral stenosis of distal graft anastomoses. Prior to MAT, there was no flow through the graft. Percutaneous balloon angioplasty was performed bilaterally with 5-mm and 6-mm balloon catheters (Ultrathin, Boston Scientific, alternative to surgery. The patient agreed to undergo the procedure. The procedure was explained to the patient, and written informed consent was obtained.
The procedure was performed in the angiography suite. Both femoral arteries were prepared in a sterile fashion. The patient was placed under conscious sedoanalgesia with dormicum and fentanyl and was monitored. After placing a vascular sheath into the femoral artery, heparin was administered at a dose of 5000 IU. An aortogram obtained through a left brachial artery puncture revealed total occlusion of the infrarenal abdominal aorta, the main body and both limbs of the graft ( (Fig. 2c) . A small fragment of the thrombus embolized to the right popliteal artery. An ultrasound-guided antegrade puncture was made into the right superficial femoral artery, and a 6 F vascular sheath was inserted. The embolized thrombus was aspirated with a 6 F guiding catheter after two passes. Complete aspiration of the aortobifemoral graft took 25 min, including 13 min of fluoroscopy. The total procedure took 135 min, with 19 min of fluoroscopy time.
Immediately after the procedure and the following day, the patient received a therapeutic dosage of heparin as an intravenous infusion with a target partial thromboplastin time of 60-90 s. The patient was discharged the day after surgery and was given acetylsalicylic acid (to be continued lifelong) and warfarin for 6 months. The patient's symptoms resolved after the intervention. Follow-up included clinical examination, ankle brachial index measurement, and Doppler ultrasonography. This follow-up was performed at 1 month, 3 months, 1 year, and 2 years and demonstrated the patency of the graft. The patient has remained asymptomatic for two years.
Discussion
Chronic and occlusive iliac disease is often managed by insertion of a bypass graft. When placed in the suprainguinal position, the prosthetic grafts have good function and long-term patency. Late prosthetic graft thrombosis occurs in 10%-15% of aortofemoral bypass operations within five years of surgery (2) . Retrograde thrombectomy through the distal anastomosis is a simple and effective way to reestablish graft patency with low morbidity and mortality. However, when acute occlusion of the bypass grafts occurs, it requires emergency reoperation in nearly 50% of patients, and adequate preoperative preparation is rarely possible. When bypass grafts fail, the ensuing repeated surgeries have less favorable short-term and long-term outcomes (3, 4) .
Percutaneous CDT is a minimally invasive method to reestablish the patency of acute graft thromboses. This method requires angiography, placement of an infusion catheter into the thrombosed graft and infusion of a thrombolytic agent such as urokinase or tissue plasminogen activator. In situ graft thrombolysis is as effective as surgical thrombectomy and reestablishes flow in 60%-80% of cases (4). Postoperative angiography is also performed using this method of thrombolysis. In up to 80% of late prosthetic graft thrombosis cases, there is an underlying cause, such as stenosis proximal or distal to the graft or kinking or elongation of the graft (4). Treatment of the underlying cause is critical, as thrombolysis alone is not an adequate approach to therapy (1) . Local (intrathrombus) thrombolysis is usually effective in dissolving the thrombus and unmasking the underlying lesion, but has many limitations, such as failure to reestablish flow in 20%-40% of cases, which then mandates surgical thrombectomy, a complication rate of 15%-25%, distal embolization, and required infusions for 12-48 hours (5, 6) . The long infusion times required for the use of a local thrombolytic agent may also cause delays in the treatment and may place the extremities of the patient in danger. More effective delivery of the local thrombolytic agent may improve patency, reduce side effects, and decrease the need for prolonged infusion, thereby decreasing the associated risk of bleeding complications. In this regard, mechanical thrombectomy devices seem attractive because they are able to promptly debulk the thrombus, reduce the duration of limb ischemia, decrease the need for prolonged thrombolytic infusion, and thus reduce the risk of bleeding complications. However, they are less effective when treating older adherent thrombi and have high rates of recurrent thrombosis and distal embolization, thus explaining the reason that adjunctive thrombolysis is often required with these devices. Some thrombectomy devices may lead to hemolysis and hyperkalemia as a result of the mechanical disruption of red blood cells in the path of high-velocity saline jets (1) . MAT is a simple, rapid, and cheap way of removing thrombi from the arterial circulation in the straight lower limb arteries. This method could be attempted prior to surgical embolectomy as an alternative to thrombolytic therapy (7) (8) (9) . However, the technique is limited because of the risk of dissection in native arteries, especially in the hands of inexperienced physicians (8) . The risk of dissection could possibly be ignored for grafts.
Surgical treatment of the underlying cause of thrombosis is associated with significant perioperative morbidity and limited patency compared with primary aortoiliofemoral reconstruction. The increased morbidity is frequently related to a dissection in a previously operated field, which leads to the increased occurrence of bleeding and wound infections (3) . The use of angioplasty and stenting as an adjunctive therapy to graft thrombosis has been limited to treating anastomotic disease (10) .
We used a combination of thrombus removal with aspiration thrombectomy and angioplasty and stenting to treat a delayed aortobifemoral graft thrombosis. The procedure was successful without major complications. The patient was asymptomatic and had patent grafts after 24 months of follow-up. Aspiration thrombectomy seems to be a safe and effective method to treat delayed aortobifemoral graft thrombosis. This method provides an alternative to surgical thrombectomy, especially for patients who are not good candidates for surgery.
